
While not a final decision, ASRM is pleased that the Supreme Court's ruling will allow patients continued access to mifepristone. As the case continues to unfold, ASRM urges the Court to respect scientific evidence and FDA authority.
Full statement: asrm.org/news-and-event…



English
















